Unknown

Dataset Information

0

Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor.


ABSTRACT: COX inhibitors which selectively inhibits the inducible COX-2 is an oenzyme that causes inflammation. They are clinically effective anti-inflammatory agents with less gastrointestinal and renal toxicity. However, they lack anti-thrombotic activity and hence lead to increased incidences of adverse cardiovascular trombotic events such as myocardial infarction. Therefore, there is still a need to develop better therapeutic effect and tolerability COX-2 inhibitor. The majority of COX-2 inhibitors are diaryl heterocycles. For optimum COX-2 selectivity and inhibitory potency a -SO(3)CH(3) or a- SO(2)NH(2) substituent at the para-position of phenyl ring was essential. A wide variety of heterocycles can serve as central ring system of the diaryl heterocycles structures. We report the screening of various 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety, directly or indirectly bound to the ring system, using the Protein-Ligand ANT System (PLANTS) docking software against the COX-2 enzyme. Various molecular structures of ligands were docked and scored to identify structurally similar ligands to SC-558 (reference ligand) in binding interaction to COX-2 binding site. The results show that 2,3-disubstituted-4(3H)-quinazolinones possess pbenzenesulfonamide moiety at C-2, and phenyl moiety at N-3 binds directly or indirectly to the ring system with high binding affinity. The docked ligand has orientations similar to that observed with SC-558 satisfying Lipinski's rule of five.

SUBMITTER: Hayun 

PROVIDER: S-EPMC3218419 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor.

Hayun   Yanuar Arry A   Hanafi Muhammad M   Pws Sumi Hudiyono SH  

Bioinformation 20111031 5


COX inhibitors which selectively inhibits the inducible COX-2 is an oenzyme that causes inflammation. They are clinically effective anti-inflammatory agents with less gastrointestinal and renal toxicity. However, they lack anti-thrombotic activity and hence lead to increased incidences of adverse cardiovascular trombotic events such as myocardial infarction. Therefore, there is still a need to develop better therapeutic effect and tolerability COX-2 inhibitor. The majority of COX-2 inhibitors ar  ...[more]

Similar Datasets

| S-EPMC3154515 | biostudies-literature
| S-EPMC4120575 | biostudies-literature
| S-EPMC5438335 | biostudies-literature
| S-EPMC4822229 | biostudies-literature
| S-EPMC3380807 | biostudies-literature
| S-EPMC10660482 | biostudies-literature
| S-EPMC2968793 | biostudies-literature
| S-EPMC3435752 | biostudies-literature
| S-EPMC5636001 | biostudies-literature
| S-EPMC2527062 | biostudies-literature